Radiation Enhances the Efficacy of Antitumor Immunotherapy with an Immunocomplex of Interleukin-2 and its Monoclonal Antibody
- 3 December 2017
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (12) , 6799-6806
Abstract
Aim: An immunocomplex of interleukin-2 (IL-2) and its monoclonal antibody, S4B6 (IL-2/S4B6), contributes to antitumor immune systems. We investigated the antitumor efficacy of radiation (IR) combined with IL-2/S4B6 for osteosarcoma. Materials and Methods: LM8 mouse osteosarcoma cells were inoculated into both legs of C3H mice. For groups treated with IL-2/S4B6 alone, and those treated with IR combined with IL-2/S4B6 (COMB), IL-2/S4B6 was intraperitoneally administered on days 12 and 16 after tumor cell inoculation. For groups treated with IR alone or COMB, one side leg was irradiated at 10 Gy on day 12. Results: Although monotherapy with IL-2/S4B6 provided no significant tumor growth inhibition, combined therapy significantly reduced tumor volume in both irradiated and unirradiated tumors by 99% and 58%, respectively, compared to the no-treatment group, with significant induction of CD8+ T-cells in unirradiated tumors. Moreover, the combination therapy significantly prolonged overall survival. Conclusion: Radiation combined with IL-2/S4B6 may be a potential therapeutic option for therapy of osteosarcoma.Keywords
This publication has 30 references indexed in Scilit:
- Combination Effect of Regulatory T-Cell Depletion and Ionizing Radiation in Mouse Models of Lung and Colon CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational MechanismsImmunity, 2015
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancerNature, 2015
- Therapeutic immunization and local low‐dose tumor irradiation, a reinforcing combinationInternational Journal of Cancer, 2013
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and ImmunotherapyImmunity, 2013
- Isolating, immunophenotyping and ex vivo stimulation of CD4+ and CD8+ gastric lymphocytes during murine Helicobacter pylori infectionJournal of Immunological Methods, 2012
- Maximizing Tumor Immunity With Fractionated RadiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Radiation Enhances Regulatory T Cell RepresentationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Antitumor activity of IL‐2/anti‐IL‐2 mAb immunocomplexes exerts synergism with that of N‐(2‐hydroxypropyl)methacrylamide copolymer‐bound doxorubicin conjugate due to its low immunosuppressive activityInternational Journal of Cancer, 2010
- Overview of interleukin-2 function, production and clinical applicationsCytokine, 2004